|
Volumn 296, Issue 5568, 2002, Pages 692-695
|
Schizophrenia: Diverse approaches to a complex disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GENES;
MEDICAL IMAGING;
NEUROLOGY;
GENETIC ABERRATIONS;
DISEASES;
AMPHETAMINE;
CHLORPROMAZINE;
CLOZAPINE;
CYCLOSERINE;
DOPAMINE;
DOPAMINE RECEPTOR;
GLUTAMIC ACID;
GLYCINE;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
NEUROLEPTIC AGENT;
OLANZAPINE;
PHENCYCLIDINE;
PSYCHEDELIC AGENT;
QUETIAPINE;
RISPERIDONE;
SERINE;
SEROTONIN;
DISEASE;
MENTAL HEALTH;
CHROMOSOMAL LOCALIZATION;
DOPAMINERGIC TRANSMISSION;
DRUG EFFECT;
DRUG EFFICACY;
ENVIRONMENTAL FACTOR;
GENETIC DAMAGE;
GENETIC SUSCEPTIBILITY;
HEREDITY;
HUMAN;
MENTAL DISEASE;
NERVE CELL DIFFERENTIATION;
NEUROANATOMY;
NEUROTRANSMISSION;
NONHUMAN;
PRIORITY JOURNAL;
REVIEW;
SCHIZOPHRENIA;
SEROTONINERGIC SYSTEM;
ANTIPSYCHOTIC AGENTS;
BRAIN;
CHROMOSOME MAPPING;
DISEASE SUSCEPTIBILITY;
GENETIC PREDISPOSITION TO DISEASE;
HUMANS;
MUTATION;
NEUROTRANSMITTER AGENTS;
POLYMORPHISM, GENETIC;
RECEPTORS, NEUROTRANSMITTER;
RISK FACTORS;
SCHIZOPHRENIA;
|
EID: 0037177552
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.1070532 Document Type: Review |
Times cited : (486)
|
References (35)
|